Shannon L. Maude, MD, PhD, highlighted promising long-term disease-free survival and MRD negativity with tisagenleucel in ...

Melanocyte melanin synthesis creates constitutive ROS vulnerability, and impaired Nrf2-mediated antioxidant responses enable ...

Treatment Selection and Eligibility in Follicular Lymphoma,' Ryan Haumschild, PharmD, MS, MBA, CPEL led the conversation ...

Forging multistakeholder partnerships and prioritizing high-impact specialities can help convert market volatility to an advantage. An aging population, growing chronic disease burden, and higher ...

In this episode, 'Diagnosing Alopecia Areata: Differential Diagnosis, Comorbidities, and Disease Burden,' the expert ...

Welcome back to another AJMC Insights series. In this episode titled, 'Recognizing Alopecia Areata: Pathophysiology, Medical ...

“MS is not associated with increased in-hospital mortality or complications in patients undergoing cardiovascular surgery, ...

Nerandomilast (Jascayd; Boehringer Ingelheim) received a recommendation for marketing authorization from the European ...

Adhering to the current guideline standard for intraoperative nodal assessment in resected non–small cell lung cancer (NSCLC) ...

State data reveal 2026 ACA marketplace enrollment losses are accelerating post open enrollment, as cancellations surge and ...

Alopecia areata affects ~2% globally and is associated with atopic/autoimmune overlap, psychological comorbidity, and a ...

Real-world diabetic macular edema care lags trials as fewer VEGF injections and step therapy limit outcomes. Persistent ...